AMNI — Amniotics AB (publ) Share News
0.000.00%
- SEK14.64m
- SEK9.00m
Brief: Amniotics H1 Net Revenue SEK 2.5 Million
Brief: Amniotics Gets Conditional Approval To Delist From Nasdaq First North Growth Market
Brief: Amniotics To Delist From Nasdaq First North Growth Market Upon Magle Group Merger Completion
Brief: Magle Chemoswed, Amniotics Adopt Merger Plan
Brief: Amniotics Extends SEK 3.3 Mln Loan Agreement Until End Of June
Brief: Amniotics BOD Recommends Shareholders To Accept Offer From Magle Chemoswed
Brief: Magle Recommends Cash Offer Totaling SEK 10.9 Mln To Shareholders Of Amniotics
Brief: Amniotics Extends Loan Agreement, Signs Service Deal
Brief: Amniotics Q4 EBITDA at SEK -5 Million
Brief: Amniotics Gets Orphan Designation For Pulmostem® From The European Commission
Brief: Amniotics Q3 EBITDA Loss at SEK 5.6 Million
Brief: Amniotics Gets GMP Certification Renewed
Brief: Amniotics Gets Positive Opinion On Orphan Designation For Pulmostem From EMA
Brief: Amniotics Announces Outcome In Rights Issue
Brief: Amniotics Gets Granted Patent In Singapore For Amniotic Fluid Collection Technology
Brief: Amniotics Q2 Loss For Period Narrows To SEK 6.5 Mln
Brief: Amniotics Resolves On Rights Issue Of Units
Brief: Amniotics Q2 EBITDA at SEK -6 Million
Brief: Amniotics Raises About SEK 4.7 Mln Via Exercise Of Warrants